The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform ...

and quite unexpected step of the pharma giant into the adeno-associated virus (AAV) gene therapy, vector discovery and product development. AAV vectors are responsible for transporting genes to ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the U.S. Food and Drug ...

Despite the challenges, including what CSL CEO Paul McKenzie has described as a fragmented U.S. healthcare system, the blood ...

The main problem is that most vector production technologies were developed for the lab, rather than to support industrial ...

Distribution of Ranvier nodes along myelinated axons is a critical determinant of conduction velocity, significantly influencing spike arrival timing and hence neural circuit function. The patterns of ...

The train driver told Newsweek: "I thought she was small enough to fit under the train, but I wasn't certain. I was thankful we found her alive." A lawyer on TikTok confronted ICE agents in a ...

The research reveals ... Nasal Spray H5N1 Avian Influenza Vaccine Developed Apr. 8, 2025 — Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a ...